Mouse Anti-Human CD55 Monoclonal Antibody (TJL-117) [AC](Cat#: CTMM-0322-JL918)
This product is an AC conjugated anti-Human Complement CD55 Monoclonal antibody (TJL-117) generated from the Mouse. The antibody can be used for IP.
Summary
Related Products & Services
Specifications
| Clonality |
Monoclonal |
| Clone |
TJL-117 |
| Host Animal |
Mouse |
| Isotype |
IgG2a Kappa |
| Immunogen |
Human CD55, a.a. 35-353 |
| Species Reactivity |
Human |
| Applications |
IP |
| Application Notes |
IP: 1-2 µg/mL |
| Specificity |
This antibody reacts with Human Complement CD55. |
| Purity |
≥95% as determined by SDS-PAGE |
| Conjugation |
AC |
| Format |
Liquid |
| Size |
500 µg |
| Storage |
Store in dark at 4°C. Do Not Freeze. |
| Type |
Primary Antibody |
Target
| Target Name |
CD55 |
| Alternative Names |
CD55 Molecule (Cromer Blood Group); CD55 Molecule, Decay AcceleRating Factor For Complement (Cromer Blood Group); CD55 Antigen; Decay AcceleRating Factor For Complement (CD55, Cromer Blood Group System); Complement Decay-AcceleRating Factor; Cromer Blood Group Antigen; CR; TC; DAF; CROM CHAPLE |
| Gene ID |
1604 |
| UniProt ID |
P08174 |
Information
| Introduction |
Complement decay-acceleRating factor, also known as CD55, is a protein encoded by the human CD55 gene. DAF is a 70 kDa membrane protein that attaches to cell membrane via a glycophosphatidylinositol (GPI) anchor. It recognizes C4b and C3b fragments that are created during activation of C4 (classical or lectin pathway) or C3 (alternative pathway), and regulates the complement system on the cell surface. |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
